How High Level Information and Hypothesis-Driven Research can Accelerate Industrial Drug Design- Full Interview with Dr Simon Newstead

By:
Posted: 06/26/2013

Dr Simon Newstead is a lecturer in membrane protein crystallography at the University of Oxford. In this interview, he explores why uptake transporters are important in drug development and he explores the merits of a structure based analysis. On top of this he discusses the impact of the recent ITC recommendations and how they will impact research in the next 5 years.

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

By:
Posted: 06/26/2013

Pharma IQ Members